502 related articles for article (PubMed ID: 36362222)
1. Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs.
Lulli M; Napoli C; Landini I; Mini E; Lapucci A
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362222
[TBL] [Abstract][Full Text] [Related]
2. An epigenetic modulator with promising therapeutic impacts against gastrointestinal cancers: A mechanistic review on microRNA-195.
Davoodvandi A; Rafiyan M; Asemi Z; Matini SA
Pathol Res Pract; 2023 Aug; 248():154680. PubMed ID: 37467635
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNAs in colorectal cancer.
Xie X; Tang B; Xiao YF; Xie R; Li BS; Dong H; Zhou JY; Yang SM
Oncotarget; 2016 Feb; 7(5):5226-39. PubMed ID: 26637808
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
Yang Y; Du Y; Liu X; Cho WC
Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
[TBL] [Abstract][Full Text] [Related]
5. Competitive endogenous RNA networks: Decoding the role of long non-coding RNAs and circular RNAs in colorectal cancer chemoresistance.
Khalafizadeh A; Hashemizadegan SD; Shokri F; Bakhshinejad B; Jabbari K; Motavaf M; Babashah S
J Cell Mol Med; 2024 Apr; 28(7):e18197. PubMed ID: 38506091
[TBL] [Abstract][Full Text] [Related]
6. Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers.
Zabeti Touchaei A; Vahidi S; Samadani AA
Clin Exp Med; 2024 Jan; 24(1):29. PubMed ID: 38294554
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
[TBL] [Abstract][Full Text] [Related]
8. Role of non-coding RNAs as new therapeutic targets in regulating the EMT and apoptosis in metastatic gastric and colorectal cancers.
Ebrahimi N; Hakimzadeh A; Bozorgmand F; Speed S; Manavi MS; Khorram R; Farahani K; Rezaei-Tazangi F; Mansouri A; Hamblin MR; Aref AR
Cell Cycle; 2023 Oct; 22(20):2302-2323. PubMed ID: 38009668
[TBL] [Abstract][Full Text] [Related]
9. Circulating non-coding RNAs as new biomarkers and novel therapeutic targets in colorectal cancer.
Yang L; Zhang X; Hu G
Clin Transl Oncol; 2021 Nov; 23(11):2220-2236. PubMed ID: 34275108
[TBL] [Abstract][Full Text] [Related]
10. Non-coding RNAs as Biomarkers for Survival in Colorectal Cancer Patients.
Andrabi MQ; Kesavan Y; Ramalingam S
Curr Aging Sci; 2024; 17(1):5-15. PubMed ID: 36733201
[TBL] [Abstract][Full Text] [Related]
11. Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential.
Luo ZD; Wang YF; Zhao YX; Yu LC; Li T; Fan YJ; Zeng SJ; Zhang YL; Zhang Y; Zhang X
World J Gastroenterol; 2023 Jan; 29(1):1-18. PubMed ID: 36683709
[TBL] [Abstract][Full Text] [Related]
12. Non-coding RNAs as emerging regulators and biomarkers in colorectal cancer.
Kishore C; Karunagaran D
Mol Cell Biochem; 2022 Jun; 477(6):1817-1828. PubMed ID: 35332394
[TBL] [Abstract][Full Text] [Related]
13. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
Hou W; Bonkovsky HL
World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
[TBL] [Abstract][Full Text] [Related]
14. Noncoding RNA and colorectal cancer: its epigenetic role.
Kita Y; Yonemori K; Osako Y; Baba K; Mori S; Maemura K; Natsugoe S
J Hum Genet; 2017 Jan; 62(1):41-47. PubMed ID: 27278790
[TBL] [Abstract][Full Text] [Related]
15. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer.
Tang XJ; Wang W; Hann SS
Biochimie; 2019 Aug; 163():58-72. PubMed ID: 31082429
[TBL] [Abstract][Full Text] [Related]
16. Noncoding RNAs and Colorectal Cancer: A General Overview.
Sarraf JS; Puty TC; da Silva EM; Allen TSR; Sarraf YS; de Carvalho LEW; Adami F; de Oliveira EHC
Microrna; 2020; 9(5):336-345. PubMed ID: 33349228
[TBL] [Abstract][Full Text] [Related]
17. The potential relevance of long non-coding RNAs in colorectal cancer pathogenesis and treatment: A review focus on signaling pathways.
Doghish AS; Zaki MB; Eldeib MG; Radwan AF; Moussa R; Abdel-Wahab MM; Kizilaslan EZ; Alhamshry NAA; Ashour AE; Elimam H
Pathol Res Pract; 2024 Jan; 253():155044. PubMed ID: 38141573
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
[TBL] [Abstract][Full Text] [Related]
19. The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance.
Lampropoulou DI; Pliakou E; Aravantinos G; Filippou D; Gazouli M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163397
[TBL] [Abstract][Full Text] [Related]
20. The ncRNA-TGF-β axis: Unveiling new frontiers in colorectal cancer research.
Alharbi KS
Pathol Res Pract; 2024 Feb; 254():155138. PubMed ID: 38266458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
